Literature DB >> 6429944

Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes.

G Klöppel, C R Drenck, M Oberholzer, P U Heitz.   

Abstract

The distribution and volume of the pancreatic endocrine cells were studied in a case of type 1 diabetes with a duration of approximately 7 days. Immunocytochemical techniques combined with morphometry were used. The PP-cell rich lobe, making up about 10% of the total pancreatic volume, was not included in this study. The volume density and the absolute volume of the B-cells was found to be reduced to about one third to one seventh of the values determined in four controls of similar age and/or pancreatic volume. The A-cell volume was also diminished whereas the D- and PP-cell volume remained constant. As B-cell necroses could not be detected and insulitis was in the initial stages of development it is concluded that the destruction of B-cells proceeds slowly in type 1 diabetes. In the majority of cases it probably starts years before the clinical onset of the disease.

Entities:  

Mesh:

Year:  1984        PMID: 6429944     DOI: 10.1007/bf00737292

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  17 in total

1.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

2.  [Immunocytochemical morphometry in type I and type II diabetes mellitus].

Authors:  G Klöppel; C R Drenck
Journal:  Dtsch Med Wochenschr       Date:  1983-02-04       Impact factor: 0.628

3.  Diabetes and Coxsackie virus B5 infection.

Authors:  H Champsaur; E Dussaix; D Samolyk; M Fabre; C Bach; R Assan
Journal:  Lancet       Date:  1980-02-02       Impact factor: 79.321

4.  Residual beta-cell function and islet cell antibodies in diabetic children.

Authors:  J R Crossley; A G James; R B Elliot; C C Berryman; B W Edgar
Journal:  Pediatr Res       Date:  1981-01       Impact factor: 3.756

5.  Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus.

Authors:  W Gepts; J De Mey
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

6.  Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus.

Authors:  A N Gorsuch; K M Spencer; J Lister; J M McNally; B M Dean; G F Bottazzo; A G Cudworth
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

7.  Cell populations in the endocrine pancreas of human neonates and infants.

Authors:  J Rahier; J Wallon; J C Henquin
Journal:  Diabetologia       Date:  1981-05       Impact factor: 10.122

8.  Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans.

Authors:  Y Stefan; L Orci; F Malaisse-Lagae; A Perrelet; Y Patel; R H Unger
Journal:  Diabetes       Date:  1982-08       Impact factor: 9.461

9.  The pancreatic polypeptide cells in the human pancreas: the effects of age and diabetes.

Authors:  J Rahier; J Wallon; S Loozen; A Lefevre; W Gepts; J Haot
Journal:  J Clin Endocrinol Metab       Date:  1983-03       Impact factor: 5.958

10.  Cellular composition of the human diabetic pancreas.

Authors:  J Rahier; R M Goebbels; J C Henquin
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

View more
  26 in total

1.  Increased vulnerability of newly forming beta cells to cytokine-induced cell death.

Authors:  J J Meier; R A Ritzel; K Maedler; T Gurlo; P C Butler
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

2.  Diminished glucagon suppression after β-cell reduction is due to impaired α-cell function rather than an expansion of α-cell mass.

Authors:  Juris J Meier; Sandra Ueberberg; Simone Korbas; Stephan Schneider
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-02-01       Impact factor: 4.310

Review 3.  Beta cell mass in diabetes: a realistic therapeutic target?

Authors:  J J Meier
Journal:  Diabetologia       Date:  2008-03-04       Impact factor: 10.122

4.  Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes.

Authors:  J J Meier; J C Lin; A E Butler; R Galasso; D S Martinez; P C Butler
Journal:  Diabetologia       Date:  2006-06-27       Impact factor: 10.122

5.  Changes in GAD65Ab-specific antiidiotypic antibody levels correlate with changes in C-peptide levels and progression to islet cell autoimmunity.

Authors:  E Ortqvist; B Brooks-Worrell; K Lynch; J Radtke; L M Bekris; I Kockum; C-D Agardh; C M Cilio; A L Lethagen; B Persson; A Lernmark; J Reichow; S Oak; J P Palmer; C S Hampe
Journal:  J Clin Endocrinol Metab       Date:  2010-08-04       Impact factor: 5.958

6.  Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes.

Authors:  Anna Neyman; Jennifer Nelson; Sarah A Tersey; Raghavendra G Mirmira; Carmella Evans-Molina; Emily K Sims
Journal:  Diabetes Obes Metab       Date:  2018-08-24       Impact factor: 6.577

7.  Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus.

Authors:  M Koyama; R Wada; H Sakuraba; H Mizukami; S Yagihashi
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom.

Authors:  A K Foulis; C N Liddle; M A Farquharson; J A Richmond; R S Weir
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

Review 9.  Heterogeneity of islet pathology in two infants with recent onset diabetes mellitus.

Authors:  A Lernmark; G Klöppel; D Stenger; C Vathanaprida; K Fält; M Landin-Olsson; D G Baskin; J P Palmer; A M Gown; J S Petersen
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.

Authors:  H Bärmeier; D K McCulloch; J L Neifing; G Warnock; R V Rajotte; J P Palmer; A Lernmark
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.